Janux Therapeutics (JANX) Receivables - Other: 2023-2025
Historic Receivables - Other for Janux Therapeutics (JANX) over the last 2 years, with Sep 2025 value amounting to $6.3 million.
- Janux Therapeutics' Receivables - Other rose 41.78% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 41.78%. This contributed to the annual value of $5.4 million for FY2024, which is 149.01% up from last year.
- According to the latest figures from Q3 2025, Janux Therapeutics' Receivables - Other is $6.3 million, which was up 10.96% from $5.7 million recorded in Q2 2025.
- In the past 5 years, Janux Therapeutics' Receivables - Other registered a high of $6.3 million during Q3 2025, and its lowest value of $2.2 million during Q4 2023.
- For the 3-year period, Janux Therapeutics' Receivables - Other averaged around $4.8 million, with its median value being $5.0 million (2024).
- Data for Janux Therapeutics' Receivables - Other shows a peak YoY spiked of 149.01% (in 2024) over the last 5 years.
- Over the past 3 years, Janux Therapeutics' Receivables - Other (Quarterly) stood at $2.2 million in 2023, then skyrocketed by 149.01% to $5.4 million in 2024, then surged by 41.78% to $6.3 million in 2025.
- Its Receivables - Other was $6.3 million in Q3 2025, compared to $5.7 million in Q2 2025 and $5.6 million in Q1 2025.